BREAKING! HKEx Launches New Round of Listing Mechanism Reforms

SadMoneyMeow

2026-03-15 12:27:06

Abstract generation in progress

Securities Times Reporter Wu Shun

On March 13, the Hong Kong Exchanges and Clearing Limited (HKEX), a wholly owned subsidiary of Hong Kong Exchanges and Clearing Limited, issued a consultation document seeking market feedback on a series of proposals to enhance the competitiveness of Hong Kong’s listing mechanism. The consultation period lasts for eight weeks, ending on May 8, 2026.

According to the introduction, HKEX’s proposals aim to create a more diverse and vibrant market environment, offering richer investment opportunities to better meet the needs of investors and issuers. Key measures include optimizing regulations for companies with different voting rights and facilitating overseas-listed issuers to list in Hong Kong.

Notably, this reform represents significant breakthroughs in the existing listing mechanisms on multiple levels, such as lowering financial thresholds for companies with different voting rights, increasing the ratio of different voting rights to 20:1, expanding the scope of companies allowed to submit confidential listing applications to all applicants, and requiring the disclosure of all professional institutions (not just sponsors) involved in preparing the listing application when it is rejected.

Wong Kit-sin, Head of Listing at HKEX, stated: “HKEX is committed to ensuring our listing mechanism is robust and competitive, consolidating Hong Kong’s position as a leading international financial center. Through in-depth communication with stakeholders, we found that they generally want to seize more high-quality innovative investment opportunities and hope that the listing mechanism can be more efficient and up-to-date while maintaining investor trust and confidence. Therefore, we have put forward these proposals.”

She added: “Since 2018, we have successfully implemented a series of listing reforms that fundamentally reshaped Hong Kong’s stock market structure, attracting many innovative companies to list in Hong Kong. These proposals are based on the成果 of those reforms. We welcome feedback on these proposals and look forward to continued communication with stakeholders. Let us work together to strengthen Hong Kong’s status as the preferred fundraising hub for growth companies and the top global market for capital deployment in Asia.”

Specifically, the reform proposals are divided into three parts:

1. Regulations for Companies with Different Voting Rights

		Current Regulations	Latest Proposals
1	Listing Financial Qualifications	Market cap: (A) ≥ HKD 40 billion; or (B) ≥ HKD 10 billion and revenue in the most recent audited fiscal year ≥ HKD 1 billion.	Market cap thresholds lowered to: (A) ≥ HKD 20 billion; or (B) ≥ HKD 6 billion and revenue in the most recent audited fiscal year ≥ HKD 600 million.
2	Voting Rights and Economic Interests	Different voting rights ratio ≤ 10:1.	If listed market cap ≥ HKD 40 billion, different voting rights ratio can be increased to 20:1.
		At listing, holdings with different voting rights ≥ 10% (in some cases, lower ratios are accepted).	When holdings with different voting rights at listing are ≥ HKD 4 billion, the ratio can be relaxed to ≥ 5%.
3	Innovation and External Recognition	Applicants must prove they are “innovative industry” companies to adopt different voting rights structures.	Optimize the “innovative industry” criteria, providing clear pathways for issuers with innovative business models beyond technological innovation to list with different voting rights.
		Biotech and specialized tech applicants are automatically considered “innovative industry” companies.	Expand the scope of biotech and specialized tech companies automatically deemed “innovative industry” applicants (covering all qualified biotech and specialized tech companies, even if they do not list under Chapter 18A/18C).
		Applicants must have received third-party investment from at least one senior investor.	Further clarify external recognition requirements.

2. Recommendations for Overseas-Listed Issuers

		Current Regulations	Latest Proposals
4	Eligibility for Secondary Listing	Different voting rights: listed on a qualifying exchange and maintained good compliance within two years, meeting financial thresholds for main listing with different voting rights.	Same as above, lowering the financial thresholds for main listing with different voting rights to align with those for secondary listing.
		Same share, same rights: Market cap: (A) ≥ HKD 3 billion (listed on a qualifying exchange or any recognized exchange with good compliance within five years); or (B) ≥ HKD 10 billion (listed on a qualifying exchange with good compliance within two years).	Same share, same rights: Reduce the market cap threshold for (B) from HKD 10 billion to HKD 6 billion.
5	Transition to Main Listing	Provide guidelines for converting from secondary to (dual) main listing.	Re-draft the rules for transitioning to main listing and provide more guidance on the general steps required to meet compliance.
6	Measures to Further Facilitate Overseas-Listed Issuers	Not applicable	Seek feedback on measures to further facilitate overseas-listed issuers to list in Hong Kong.

3. Initial Listing Rules and Arrangements

		Current Regulations	Latest Proposals
7	Continuity of Ownership and Control	Applicants must be under the control of the same shareholder(s) with significant influence over management within the relevant period, operating as a whole.	Incorporate existing guidelines into the Listing Rules: if an applicant can demonstrate that changes in control do not significantly impact management, it will be deemed compliant.
8	Financial Reporting Standards	Applicants listed or seeking dual main or secondary listing in Hong Kong while listed in the US may apply for exemption to adopt US GAAP.	Expand the scope to include subsidiaries of US-listed parent companies and companies with substantial US operations.
		Issuers using US GAAP must revert to Hong Kong Financial Reporting Standards or IFRS after delisting from the US.	Remove this requirement.
		Unaudited financial statements must be reviewed by auditors.	Remove this requirement.
9	Biotech and Specialized Tech Applicants with Commercialization	Biotech or specialized tech companies that meet Chapter 8 financial criteria must list via the general route under Chapter 8, not through Chapters 18A or 18C.	Allow such applicants to choose to list under Chapters 18A or 18C.
10	Confidential Submission of Listing Applications	Confidential submission options are limited to eligible secondary listing applicants, biotech, and specialized tech companies, or companies granted exemptions.	All new applicants can opt for confidential submission.
		Incomplete applications may be rejected. When rejected, the HKEX website will publish the sponsor’s identity.	Strengthen rejection procedures: upon rejection, disclose all professional institutions involved in preparing the application (not just sponsors).

(Editors: Wang Zhiqiang HF013)

【Disclaimer】This article reflects only the author’s views and is not related to Hexun.com. Hexun.com maintains neutrality regarding the statements and opinions in this article and does not guarantee the accuracy, reliability, or completeness of the content. Readers should use it for reference only and bear all responsibilities themselves. Email: news_center@staff.hexun.com

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.